Zum Inhalt springen
Back to CME Podcast

CME Q4 2025 Earnings Analysis

CME Group | 7:34 | English | 2/22/2026
CME Q4 2025 - English
0:00
7:34
Advertisement

Listen On

Available In

Key Highlights

  • Revenue and earnings analysis for Q4 2025
  • Key financial metrics and performance indicators
  • Management guidance and outlook commentary
  • Market position and competitive analysis
  • AI-generated insights and analysis

Transcript

// Full episode script

BETA FINCH PODCAST SCRIPT

A
Alex

Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into CME Group's Q4 2025 results – and wow, what a quarter to cap off what they're calling their most successful year ever. Now, before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions. Jordan, CME just posted some pretty impressive numbers here. Walk us through the highlights.

J
Jordan

Absolutely, Alex. This was a record-breaking quarter on multiple fronts. CME hit $1.65 billion in Q4 revenue, up 8% year-over-year, and for the full year they reached $6.5 billion – their fourth consecutive year of record revenues. But here's what really caught my eye: adjusted earnings per share grew 10% in the quarter to $2.77, and 9% for the full year.

A
Alex

And those volume numbers were pretty staggering too, right?

J
Jordan

Exactly. They averaged 28.1 million contracts daily for the year – up 6% and marking their fifth consecutive year of record volume. What's particularly interesting is this growth was broad-based across all their major asset classes. Interest rates, energy, metals, agricultural products, and crypto all hit all-time records.

A
Alex

Speaking of crypto, that seems to be a major growth driver for them. What's happening there?

J
Jordan

Crypto was absolutely on fire for CME. Q4 average daily volume hit 379,000 contracts – that's up 92% year-over-year, representing over $13 billion in notional value traded per day. And CEO Terry Duffy announced they're launching Cardano, Chainlink, and Stellar futures next week, plus they're rolling out 24/7 crypto trading next quarter.

A
Alex

That's a big strategic shift. They're essentially saying crypto doesn't sleep, so neither should their platform.

J
Jordan

Exactly, and Duffy made an interesting comment during the call about potentially expanding 24/7 trading to other asset classes if it makes sense. They're clearly being responsive to how markets are evolving, especially since the underlying crypto cash markets trade through weekends.

A
Alex

Now, one area that's getting a lot of attention is their push into retail markets. They launched these "event contracts" – basically prediction markets. How's that going?

J
Jordan

This is fascinating, Alex. They launched in December and have already seen over 68 million event contracts traded in just six weeks, including 7 million on market-related events. They're partnering with FanDuel for distribution, and their micro products – aimed at retail traders – were up 59% in Q4 to 4.4 million contracts daily.

A
Alex

But there was some interesting commentary about the regulatory landscape here, wasn't there?

J
Jordan

Yes, and Duffy was pretty direct about this during the Q&A. He emphasized that as long as the CFTC regulates these as swaps – which they currently do – CME will participate. But he was clear they don't want to get bogged down in legal battles with states over whether this constitutes gambling. His position is basically: "We follow federal regulation, and if states have issues, they should take it up with the federal government, not us."

A
Alex

That's a pretty pragmatic stance. Now, looking at their financials, margins were strong again, right?

J
Jordan

Very strong. Operating margin for the year was 69.4%, up 110 basis points from 2024. For Q4 specifically, they hit a 67% operating margin. They're also sitting on about $4.6 billion in cash, including $1.3 billion from their Austria sale proceeds, which the board has approved for share buybacks.

A
Alex

And they're continuing to invest in growth initiatives. What's the 2026 guidance looking like?

J
Jordan

They're guiding for about 1% to 1.5% revenue growth on similar activity levels, factoring in recent fee increases. But here's the key – they're expecting adjusted operating expenses of about $1.695 billion, which includes increased investment in those new initiatives we talked about: 24/7 crypto trading, securities clearing, and event contracts.

A
Alex

One thing that stood out to me was their market data business hitting over $800 million for the first time. That's become a real revenue driver.

J
Jordan

It's incredible – thirty-one consecutive quarters of growth in that segment. Julie Winkler, their chief commercial officer, broke down the growth drivers: 50% from new users, 25% from product innovation, and 25% from pricing integrity. They implemented a 3.5% rate increase on January 1st, and the business seems pretty resilient to competitive pressures.

A
Alex

There was also discussion about their Google Cloud migration and some interesting blockchain initiatives. What's happening there?

J
Jordan

The Google Cloud migration is progressing well – they expect to complete non-ultra-low latency migration early this year, with ultra-low latency testing planned for 2027. On the blockchain side, Duffy mentioned they're working on tokenized collateral initiatives and even potentially their own coin for industry participants. But he was careful to note they won't accept tokens from just anyone – it depends on who's issuing them and the associated risk.

A
Alex

Looking at the big picture, what does this all mean for investors?

J
Jordan

CME is executing on multiple fronts simultaneously. They're maintaining their core derivatives business leadership while expanding into retail markets, crypto, and new clearing services. The margin expansion shows operational leverage, and they're returning capital to shareholders while investing for growth. The fact that they're seeing record volumes across multiple asset classes suggests their competitive moat remains strong.

A
Alex

Any concerns or things to watch?

J
Jordan

The main thing I'd watch is execution risk. They're launching a lot of new initiatives – 24/7 trading, securities clearing, prediction markets – while managing a major technology migration. That's a lot of moving pieces. Also, the prediction markets face regulatory uncertainty, though management seems confident in their approach. The expense guidance of $1.695 billion represents meaningful investment, so investors will want to see those initiatives translate to revenue growth over time.

A
Alex

Jordan, before we wrap up, what's your take on CME's positioning heading into 2026?

J
Jordan

I think they're in a strong position. They've got this diversified platform that benefits from volatility across multiple asset classes, they're expanding their addressable market with retail products, and they're maintaining healthy margins while investing for growth. The $25 billion in daily margin savings they're providing clients shows the value proposition remains compelling. Everything discussed today is AI-generated analysis for educational purposes. Past performance doesn't guarantee future results. Please do your own due diligence.

A
Alex

That wraps up our breakdown of CME Group's Q4 results. Record revenues, expanding into new markets, and investing heavily in their future – definitely a lot to digest. Thanks for joining us on Beta Finch, and we'll see you next time for another AI-powered earnings breakdown. ---

[END TRANSCRIPT]

Total word count: ~1,150 words

Estimated runtime: ~6-7 minutes

Share This Episode

Advertisement